Recombinant Viruses

A recombinant vaccine is a vaccine developed through recombinant DNA technology. Vaccine approaches to contagious diseases are widely applied and appreciated. Amongst them, vectors based on recombinant viruses have displayed great promise and play a crucial role in the instigation of new vaccinations. Many viruses have been examined for their ability to express proteins from foreign pathogens and induce specific immunological responses against these antigens in vivo. Generally, gene-based vaccines can trigger potent humoral and cellular immune responses and viral vectors might be an effective strategy for both the delivery of antigen-encoding genes and the facilitation and enhancement of antigen presentation.

Recent methods in the diagnosis of viral infections:

    Related Conference of Recombinant Viruses

    September 07-08, 2026

    38th Annual Congress on Vaccine and Clinical Trials

    London, UK
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain
    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Recombinant Viruses Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in